Valuation : Balchem Corporation

Market Cap 5.24B 4.52B 4.28B 3.88B 7.27B 501B 7.31B 50.75B 19.51B 254B 19.68B 19.25B 805B P/E 2026 *
30.4x
P/E 2027 * 29.2x
Enterprise Value 5.28B 4.55B 4.31B 3.9B 7.32B 504B 7.36B 51.09B 19.64B 256B 19.81B 19.38B 810B EV / Sales 2026 *
4.66x
EV / Sales 2027 * 4.35x
Free-Float
99.53%
Yield 2026 *
0.71%
Yield 2027 * 0.79%
1 day-1.37%
1 week-4.21%
Current month-6.54%
1 month-8.55%
3 months-0.39%
6 months-3.51%
Current year+7.19%
1 week 164.16
Extreme 164.16
171.27
1 month 164.16
Extreme 164.16
182.99
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 65.37
Extreme 65.37
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Controller/Auditor

8,646 0.0270%
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-4.21%+5.15%+25.14% 5.24B
+1.69%-1.11%+1.31%+51.65% 77.42B
-0.16%-3.62%-0.24%-23.90% 36.38B
+0.16%-2.65%-7.51%+9.75% 35.8B
-0.22%-2.66%-11.11%+10.24% 25.11B
+0.13%+0.89%+31.79%+22.56% 22.82B
-3.60%-8.57%+66.50%+20.17% 19.96B
-0.26%-3.50%-45.23%-43.70% 17.15B
-3.43%-6.94%+54.67%-36.25% 13.87B
-0.86%-3.54%+7.44%-4.47% 13.84B
Average -0.79%-3.65%+10.28%+3.12% 26.76B
Weighted average by Cap. -0.06%-2.87%+6.39%+12.97%

Financials

2026 *2027 *
Net sales 1.13B 976M 924M 837M 1.57B 108B 1.58B 10.96B 4.21B 54.95B 4.25B 4.16B 174B 1.2B 1.03B 976M 885M 1.66B 114B 1.67B 11.58B 4.45B 58.06B 4.49B 4.39B 184B
Net income 175M 151M 143M 129M 242M 16.71B 244M 1.69B 651M 8.49B 657M 642M 26.85B 182M 157M 149M 135M 253M 17.41B 254M 1.76B 679M 8.85B 684M 669M 27.98B
Net Debt 35.51M 30.62M 28.98M 26.27M 49.25M 3.39B 49.54M 344M 132M 1.72B 133M 130M 5.45B -39.68M -34.22M -32.38M -29.35M -55.03M -3.79B -55.35M -384M -148M -1.93B -149M -146M -6.09B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
26-09-11 US$164.39 -1.37% 250,642
26-09-10 US$166.67 -0.99% 127,765
26-09-09 US$168.34 -1.30% 121,657
26-09-08 US$170.56 -0.61% 138,261
26-09-04 US$171.61 -0.08% 89,947
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
164.39USD
Average target price
209.25USD
Spread / Average Target
+27.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!